Erythromycin estolate (CAS No 3521-62-8) is a macrolide antibiotic commonly used in biomedical research due to its bacteriostatic properties It originates from the actinomycete Saccharopolyspora erythraea and is known for its ability to inhibit protein synthesis by binding to the 50S ribosomal subunit thereby interfering with the translocation of peptides In vitro erythromycin estolate demonstrates activity in the nanomolar to low micromolar range This compound is frequently applied in studies involving various bacterial strains serving as a tool for exploring antimicrobial resistance and as a standard in drug susceptibility assays It is also used in animal models to investigate the pharmacokinetics and pharmacodynamics associated with antimicrobial therapies Experimental concentrations typically depend on the specific research design ensuring relevance and accuracy in different experimental setups